Factors Influencing Patient Adherence to Tuberculosis Treatment in Ethiopia: A Literature Review.


Journal

International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455

Informations de publication

Date de publication:
04 08 2020
Historique:
received: 12 06 2020
revised: 22 07 2020
accepted: 28 07 2020
entrez: 8 8 2020
pubmed: 8 8 2020
medline: 18 11 2020
Statut: epublish

Résumé

Tuberculosis (TB) is a major global public health problem and one of the leading causes of death among infectious diseases. Although TB can be cured with first-line antibiotics treatment of 6 months regimen, non-adherence to the treatment remains the main challenge for TB prevention and control. Interventions to promote adherence need to address multiple underlying factors linked to non-adherence, which requires a synthesis of studies to understand these factors in the local context. Our review accordingly examines these factors for TB treatment in Ethiopia. Articles were searched from PubMed and ScienceDirect databases, as well as manual searches through Google and Google Scholar search engines. Both quantitative and qualitative studies that showed factors associated with or reasons for non-adherence, default or loss to follow up from TB treatment were included. A total of 276 articles were screened, and 29 articles were ultimately included in the review. The extracted factors were synthesized thematically into seven dimensions of patient-centred, social, economic, health system, therapy, lifestyle, and geographic access factors. More than 20 distinct factors were identified under these headings. Some of these factors may also apply quite widely in other settings, with greater or lesser influence, but some are particularly applicable to the Ethiopian setting. Helping patients to achieve full adherence to TB medication is a complex problem as it is influenced by interplay between many factors. Healthcare managers, providers, and researchers need to consider and address multiple underlying factors when designing adherence interventions. This work provides a reference set of such factors for Ethiopian interventions.

Sections du résumé

BACKGROUND
Tuberculosis (TB) is a major global public health problem and one of the leading causes of death among infectious diseases. Although TB can be cured with first-line antibiotics treatment of 6 months regimen, non-adherence to the treatment remains the main challenge for TB prevention and control. Interventions to promote adherence need to address multiple underlying factors linked to non-adherence, which requires a synthesis of studies to understand these factors in the local context. Our review accordingly examines these factors for TB treatment in Ethiopia.
METHODS
Articles were searched from PubMed and ScienceDirect databases, as well as manual searches through Google and Google Scholar search engines. Both quantitative and qualitative studies that showed factors associated with or reasons for non-adherence, default or loss to follow up from TB treatment were included. A total of 276 articles were screened, and 29 articles were ultimately included in the review.
FINDINGS
The extracted factors were synthesized thematically into seven dimensions of patient-centred, social, economic, health system, therapy, lifestyle, and geographic access factors. More than 20 distinct factors were identified under these headings. Some of these factors may also apply quite widely in other settings, with greater or lesser influence, but some are particularly applicable to the Ethiopian setting.
CONCLUSION
Helping patients to achieve full adherence to TB medication is a complex problem as it is influenced by interplay between many factors. Healthcare managers, providers, and researchers need to consider and address multiple underlying factors when designing adherence interventions. This work provides a reference set of such factors for Ethiopian interventions.

Identifiants

pubmed: 32759876
pii: ijerph17155626
doi: 10.3390/ijerph17155626
pmc: PMC7432798
pii:
doi:

Substances chimiques

Antitubercular Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : FIC NIH HHS
ID : D43 TW009127
Pays : United States

Références

Int J Tuberc Lung Dis. 2016 Oct;20(10):1342-1347
pubmed: 27725045
BMC Infect Dis. 2015 Sep 30;15:405
pubmed: 26423277
Infect Dis Poverty. 2017 Dec 15;6(1):167
pubmed: 29241454
N Am J Med Sci. 2012 Feb;4(2):67-71
pubmed: 22408750
BMC Public Health. 2011 Dec 12;11:916
pubmed: 22151609
Patient Prefer Adherence. 2017 Apr 10;11:743-749
pubmed: 28435232
BMC Res Notes. 2018 Oct 1;11(1):691
pubmed: 30285907
BMC Public Health. 2017 Mar 20;17(1):269
pubmed: 28320351
J Infect Public Health. 2017 Sep - Oct;10(5):527-533
pubmed: 28189508
PLoS Med. 2007 Feb;4(2):e37
pubmed: 17298164
Int J Tuberc Lung Dis. 2002 Jul;6(7):573-9
pubmed: 12102295
PLoS One. 2019 Jan 10;14(1):e0210422
pubmed: 30629684
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
PLoS One. 2017 Aug 1;12(8):e0181205
pubmed: 28763456
Int J Tuberc Lung Dis. 2019 Jun 1;23(6):741-749
pubmed: 31315708
Int J Tuberc Lung Dis. 2002 May;6(5):378-88
pubmed: 12019913
Pan Afr Med J. 2014 Jan 17;17:26
pubmed: 24932337
Bull World Health Organ. 2008 Mar;86(3):B-D
pubmed: 18368191
BMC Health Serv Res. 2013 Mar 22;13:110
pubmed: 23521921
BMC Public Health. 2008 Jan 11;8:11
pubmed: 18186946
Ethiop J Health Sci. 2017 Sep;27(5):447-458
pubmed: 29217949
BMC Res Notes. 2015 Sep 29;8:503
pubmed: 26420164
Public Health Action. 2014 Dec 21;4(Suppl 3):S31-6
pubmed: 26478511
Ethiop Med J. 2004 Oct;42(4):247-53
pubmed: 16124124
BMC Public Health. 2013 May 01;13:424
pubmed: 23634650
PLoS One. 2013 Nov 11;8(11):e78791
pubmed: 24244364
Tuberc Res Treat. 2018 Feb 18;2018:3705812
pubmed: 29670768
Health Policy Plan. 2009 Nov;24(6):457-66
pubmed: 19651709
Iran J Public Health. 2015 Jan;44(1):1-11
pubmed: 26060770
BMC Public Health. 2010 Oct 28;10:651
pubmed: 21029405
BMJ Glob Health. 2018 Oct 11;3(5):e001018
pubmed: 30364330
BMC Public Health. 2018 Apr 10;18(1):462
pubmed: 29631558
Ethiop J Health Sci. 2018 Sep;28(5):519-528
pubmed: 30607066

Auteurs

Zekariyas Sahile Nezenega (ZS)

Department of Public Health, Ambo University, Ambo, Ethiopia.
Flinders Digital Health Research Centre, College of Nursing & Health Sciences, Flinders University, Adelaide SA 5001, Australia.

Lua Perimal-Lewis (L)

Flinders Digital Health Research Centre, College of Science & Engineering, Flinders University, Adelaide SA 5001, Australia.

Anthony John Maeder (AJ)

Flinders Digital Health Research Centre, College of Nursing & Health Sciences, Flinders University, Adelaide SA 5001, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH